News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Array BioPharma, Inc. (ARRY) to Present at the Piper Jaffray Annual Healthcare Conference


11/15/2012 10:42:50 AM

BOULDER, Colo., Nov. 15, 2012 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Piper Jaffray Annual Healthcare Conference in New York City.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.  

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

Event:

Piper Jaffray Annual Health Care Conference

Presenter:

Ron Squarer, Chief Executive Officer

Date:

Tuesday, November 27, 2012

Time:

11:30 a.m. Eastern Time

Location:

The New York Palace, NY

Webcast:

www.arraybiopharma.com

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted smallmolecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two whollyowned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib (with AstraZeneca), MEK162 (with Novartis), and danoprevir (with InterMune / Roche), having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013.  For more information on Array, please go to www.arraybiopharma.com.

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

SOURCE Array BioPharma Inc.


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES